ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1437

Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Discrepancies between DNA index by flow cytometry and cytogenetic studies in childhood β-lymphoblastic leukemia

4th International Conference and Exhibition on Pathology

Nour Al-Mozain1, Ayman Mashi2, Asim Belgaumi3, Suleimman Al-Sweedan4, Faisal Rawas4, Sahar Ramadan4 and Randa Al Nounou4

ScientificTracks Abstracts-Workshop: J Clin Exp Pathol

DOI: 10.4172/2161-0681.S1.016

Abstract
Objectives: To estimate the reliability of flow cytometry in the early classification of childhood acute lymphoblastic leukemia (B-ALL) and to analyze the causes of discrepancies between the DNA index by flow cytometry (DNAI-FCM) and the cytogenetic studies (CG);(Karyotype and Fluorescent in situ hybridization; FISH). Methods: DNAI-FCM and CG (Karyotype and FISH) were analyzed in 69 consecutive children, newly diagnosed with acute B-lymphoblastic leukemia (B-ALL) in King Faisal Specialist Hospital between the years 2012 and 2014. Results: A statistically significant correlation existed between DNAI-FCM and CG (p = 0.001). DNAI-FCM was proportional to CG in (57/69) 82.6% of the cases. There was a discrepancy between the DNAI-FCM and the CG in (12/69) 17.4% of the cases. Ten cases had a DNAI-FCM of 1 and were hyperdiploid (47-50) by karyotype and/or FISH, one case had a DNAI-FCM of 0.8 with a diploid karyotype and hyperdiploid by FISH. One case had DNAI-FCM of 1.14 and diploid karyotype while FISH was not done. In studying these cases, three cases showed a hyperdiploid karyotype detected in less than 10% of the cells by FISH or small number of cells by karyotype. One case had DNAI-FCM of 1.14, karyotype revealed a diploid number of chromosomes in 4 cells, while FISH was not done due to insufficient quantity. Four cases exhibit trisomy or tetrasomy 21 in almost 100% of the cells by FISH, while compared to the matching cases 24/ 57 have extra copies of chromosome 21. These extra copies in 22/24 are exclusively along with extra copies of chromosome 4, 10, 17. 2/24, karyotype was not done and they were negative for the B-ALL FISH panel. Trisomy 4,10,17 are detected in (47-50) hyperdiploid cases. The cause of the discrepancy in the remaining 4 cases was not clear. Conclusion: DNAI-FCM is 82.6% reliable in the early classification of childhood B-ALL with a predictive value of 81%. Discrepancies do occur in 17.4%. In 66.66% this mismatch refers to either the small size of the chromosome or to an insufficient genetic material representing abnormality.
Biography
Nour Al-Mozain has graduated from the King Khalid University Hospital, College of Medicine with a second degree honor. She is currently a resident in King Saud Fellowship of Hematopathology.
Top